Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

PDS Biotechnology Corporation (PDSB) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

PDS Biotechnology Corporation (PDSB), most recent 12 months reported: net loss $33.67M, free cash flow -$27.75M. Latest balance sheet on file: liquid cash $5.6M. From SEC filings. Others in Pharmaceutical Preparations: Oruka Therapeutics, Inc. · OS THERAPIES INCORPORATED · Oncotelic Therapeutics, Inc. · Processa Pharmaceuticals, Inc. · PEPGEN INC. · Phio Pharmaceuticals Corp. · PROTOKINETIX, INCORPORATED · PLIANT THERAPEUTICS, INC.

Stock screener

Watchlist